Pulmonary hypertension in patients with stage 1-3 chronic kidney disease

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5695-5703

  Yang, Q M ^a   Bao, X R ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Pulmonary artery pressure; Pulmonary hypertension

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR FUNCTION; CHINESE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRESSURE MEASUREMENT; PREVALENCE; PULMONARY HYPERTENSION; PULMONARY SYSTOLIC ARTERY PRESSURE; ADOLESCENT; AGED; BLOOD PRESSURE; COMPLICATION; HYPERTENSION, PULMONARY; KIDNEY FAILURE, CHRONIC; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, PULMONARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PULMONARY ARTERY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; YOUNG ADULT;

EID: 84905018427     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.25.25     Document Type: Article

References (34)

1. Abdelwhab S and Elshinnawy S (2008). Pulmonary hypertension in chronic renal failure patients. Am. J. Nephrol. 28: 990-997.
2. Agarwal R (2012). Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol. Dial. Transplant. 27: 3908-3914.
3. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, et al. (2009). Diagnosis and assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 54: S55-S66.
4. Berger M, Haimowitz A, Van Tosh A, Berdoff RL, et al. (1985). Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J. Am. Coll. Cardiol. 6: 359-365.
5. Bozbas SS, Akcay S, Altin C, Bozbas H, et al. (2009). Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant. Proc. 41: 2753-2756.
6. Buemi M, Senatore M, Gallo GC, Crasci E, et al. (2007). Pulmonary hypertension and erythropoietin. Kidney Blood Press Res. 30: 248-252.
7. Cargill RI and Lipworth BJ (1995). Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans. Br. J. Clin. Pharmacol. 40: 585-590.
8. Casas-Aparicio G, Castillo-Martínez L, Orea-Tejeda A, Abasta-Jiménez M, et al. (2010). The effect of successful kidney transplantation on ventricular dysfunction and pulmonary hypertension. Transplant. Proc. 42: 3524-3528.
9. Domenici A, Luciani R and Principe F (2010). Pulmonary hypertension in dialysis patients. Perit. Dial. Int. 30: 251-252.
10. Etemadi J, Zolfaghari H, Firoozi R, Ardalan MR, et al. (2012). Unexplained pulmonary hypertension in peritoneal dialysis and hemodialysis patients. Rev. Port. Pneumol. 18: 10-14.
11. Fabbian F, Cantelli S, Molino C, Pala M, et al. (2011). Pulmonary hypertension in dialysis patients: a cross-sectional italian study. Int. J. Nephrol. 2011: 1-4.
12. Giaid A (1998). Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 114: 208S-212S.
13. Giaid A and Saleh D (1995). Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333: 214-221.
14. Havlucu Y, Kursat S, Ekmekci C and Celik P (2007). Pulmonary hypertension in patients with chronic renal failure. Respiration 74: 503-510.
15. Himelman RB, Struve SN, Brown JK, Namnum P, et al. (1988). Improved recognition of cor pulmonale in patients with severe chronic obstructive pulmonary disease. Am. J. Med. 84: 891-898.
16. Issa N, Krowka MJ, Griffin MD, Hickson LJ, et al. (2008). Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 86: 1384-1388.
17. Kiykim AA, Horoz M, Ozcan T, Yildiz I, et al. (2010). Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition. Ren. Fail. 32: 1148-1152.
18. Kumbar L, Fein PA, Rafiq MA, Borawski C, et al. (2007). Pulmonary hypertension in peritoneal dialysis patients. Adv. Perit. Dial. 23: 127-131.
19. Kunii Y, Kamada M, Ohtsuki S, Araki T, et al. (2003). Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med. Okayama 57: 191-197.
20. Lam CS, Borlaug BA, Kane GC, Enders FT, et al. (2009). Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 119: 2663-2670.
21. Lang CC, Choy AM, Henderson IS, Coutie WJ, et al. (1992). Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin. Sci. 82: 127-131.
22. Leuchte HH, Holzapfel M, Baumgartner RA, Ding I, et al. (2004). Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J. Am. Coll. Cardiol. 43: 764-770.
23. Reisner SA, Azzam Z, Halmann M, Rinkevich D, et al. (1994). Septal/free wall curvature ratio: a noninvasive index of pulmonary arterial pressure. J. Am. Soc. Echocardiogr. 7: 27-35.
24. Rich S (1988). Primary pulmonary hypertension. Prog. Cardiovasc. Dis. 31: 205-238.
25. Rudski LG, Lai WW, Afilalo J, Hua L, et al. (2010). Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 23: 685-713.
26. Sakaguchi Y, Shoji T, Kawabata H, Niihata K, et al. (2011). High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin. J. Am. Soc. Nephrol. 6: 995-1000.
27. Tiengo A, Fadini GP and Avogaro A (2008). The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab. 34: 447-454.
28. Unal A, Sipahioglu M, Oguz F, Kaya M, et al. (2009). Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit. Dial. Int. 29: 191-198.
29. Vasan RS, Benjamin EJ, Larson MG, Leip EP, et al. (2002). Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288: 1252-1259.
30. Wei T, Zeng C, Chen L, Chen Q, et al. (2005). Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur. J. Heart Fail. 7: 75-79.
31. Yigla M, Nakhoul F, Sabag A, Tov N, et al. (2003). Pulmonary hypertension in patients with end-stage renal disease. Chest 123: 1577-1582.
32. Yigla M, Fruchter O, Aharonson D, Yanay N, et al. (2009). Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 75: 969-975.
33. Zoccali C (2007). The endothelium as a target in renal diseases. J. Nephrol. 20 (Suppl 12): S39-S44.
34. Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, et al. (2001). Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358: 2113-2117.